Actinium Pharmaceuticals Inc (ATNM)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
37,729,700
EV to revenue ratio (TTM)
0.056
EV to ebitda
0.189
Financial Performance
Revenue (TTM)
35,090,000
Gross profit (TTM)
35,090,000
EBITDA
9,791,000
Profitability
Operating margin (TTM)
78.80%
Profit margin
32.20%
Return on assets (TTM)
11.60%
Return on equity (TTM)
45.90%
Per Share Metrics
Revenue per share (TTM)
1.12
EPS
0.35
Diluted EPS (TTM)
0.35
Book value
0.96
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
3.429
Trailing P/E
3.429
Forward P/E
8.5
PEG ratio
0
Price to sales ratio (TTM)
1.075
Price to book ratio (TTM)
1.224
Growth
Quarterly earnings growth (YoY)
-100.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
2
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.054